Abstract:Objective To investigate the clinical risk factors related to the cirrhosis development in patients with hepatitis B virus infection. Methods A total of 988 participants with hepatitis B virus infection were collected for this study in Zhong Shan Hospital affiliated with Fu Dan University between January 2009 and January 2011. All of them were Chinese Han nationality from Shanghai and its surrounding area. Their information, including hepatitis history, serum test, liver imaging, and liver histology if available, were collected. They were divided into healthy recovered and chronic hepatitis group, the later was subdivided into cirrhotic group and non-cirrhotic group. The general informations and clinical determination datas were compared with statistical analysis by using SPSS 18.0 and STATA 11.0 software. Results (1) The ratio of male/female participants was 736/252, and the average age was 50.8±13.2. The numbers of participants in healthy recovered group, non-cirrhotic chronic hepatitis and cirrhotic group were 274, 285, and 429, respectively, and the average ages were 56.7±13.6, 49.2±11.5, and 47.5±13.5, respectively. Chronic hopatitis B (CHB) familial history was found in 2.2% participants of the healthy recovered group and 47.5% participants of chronic hepatitis group. The vertical infection rates were 56.3% in healthy recovered group, and 93.7% in chronic hepatitis group, which have significant difference between them. For chronic hepatitis group, the vertical rates of non-cirrhotic and cirrhotic group were 89.4% and 96.4%, respectively, which also have significant difference between them. The vertical infection was a risk factor for chronicity of hepatitis B (OR=15.02, 95% CI:9.57-23.94) and the development of cirrhosis (OR=3.15, 95%CI:1.39-7.45). The duration of disease of cirrhotic patients (44.1±9.5 years) was longer than that of non-cirrhotic CHB patients (39.3±9.8 years). The ratio of male patients in cirrhotic group was also significantly higher than that in non-cirrhotic group (70.2%) and the duration of disease for male patients (41.7±9.3 years) were shorter than that of female patients (45.0±11.4 years).(2) The levels of liver function rests were significantly different among healthy recover, non-cirrhotic, and cirrhotic group of CHB patients. There were negative correlation between HBsAg and HBV DNA in HBeAg positive patients (r=-0.43);However positive correlation in HBeAg negative patients (r=0.23) was observed. HBsAg level, which was higher than 1 000 COI, of cirrhotic patients (89.5%) was significant higher than that of non-cirrhotic patients (89.5%) (OR=1.86, 95% CI:1.18-2.94). No correlation was found betweem HBV DNA level and the duration of disease of CHB (P=0.21). Although HBV DNA level in cirrhotic group was significantly higher than that in non-cirrhotic group (2.875±2.68 log10copies/mL), the ratio of patients with HBV DNA level, which was higher than 5 log10copies/mL in cirrhotic group (31%) was significantly lower than that in non-cirrhotic group(57.2%). Conclusion The factors associated with cirrhosis development in CHB patients include duration of diseases, familial history, route of infection (vertical infection), male gender, the level of HBsAg(higher than 1 000 COI), and HBV DNA level.

Connection of Virologic Factors and Prognosis of Viral Hepatitis with Diabetes

The Impact of Early Rapid Virological Response on the Outcomes of Hepatitis B Associated Acute on Chronic Liver Failure During Antiviral Treatment

Efficacy of different therapeutic modalities for patients with acute-on-chronic liver failure induced by hepatitis B

Effects of Antiviral Effects of Agents and Prognosis of Chronic Hepatitis B

Diabetes is associated with poor short-term prognosis in patients with hepatitis B virus-related acute-on-chronic liver failure

Association of baseline vitamin D level with genetic determinants and virologic response in patients with chronic hepatitis B.

The Effect of Highly Active Antiretroviral Therapy on Liver Function in Human Immunodeficiency Virus-Infected Pediatric Patients with or Without Hepatitis Virus Co-Infection

Effect on Prognosis with Different Treatment Measurement for 618 Cases of Chronic Severe Hepatitis B

Hepatitis B-related acute-on-chronic liver failure induced by hepatotropic viral insult is associated with worse prognosis than that induced by non-virus insult

Impact Of Diabetes Mellitus On The Prognosis Of Patients With Hepatocellular Carcinoma After Curative Hepatectomy

Study on the Efficacy and Related Factors of Antiviral Therapy in Chronic Hepatitis B

Long-term prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure: a retrospective study

Effect of antiviral therapy on prognosis of patients with decompensated cirrhosis

Hepatic steatosis and development of type 2 diabetes: Impact of chronic hepatitis B and viral specific factors

The Relationship among Histopathological Indexes and Prognosis in Patients with Chronic Hepatitis B Infection

Effects of HIV Infection on Prognosis of HCV Infected Former Blood Donors

Effect of Antiviral Therapy on the Prognosis of Patients with Chronic Hepatitis B-related Cirrhosis

[Prognosis and Related Risk Factors for 465 Subjects Infected with Hepatitis C Virus in Danyang, Jiangsu Province].

Evaluation of the clinical risk factors associated with liver cirrhosis in patients with chronic hepatitis B viral infection

Clinical Features and Survival in Chinese Patients with Hepatitis B E Antigen-Negative Hepatitis B Virus-Related Cirrhosis

Prognostic Analysis in Chronic Hepatitis B Patients: a Retrospective Study of 216 Cases about Scheuer Scores, in Situ Expression of Viral Antigens and Tissue Hepatitis B Virus DNA Levels